Ophthalmic diagnostic device maker ObjectiVision’s amended claims for damages, filed after a 25-day patent hearing, are “outlandish” and “unfair,” the University of Sydney has told the Federal Court.
$39M in settlements reached in class actions against Sandhurst Trustees
5 things to watch in the GetSwift class action appeal
Three senior Federal Court judges will hear arguments Monday and Tuesday in a closely-watched appeal of a ruling that stayed two of three competing shareholder class actions against GetSwift as an abuse of process, and the impact of the Full Court’s ruling will be felt for a long time to come. Here are five major issues the court will be wrestling with over the next two days.